This Grocery Stock Belongs in Your TFSA. Pronto!

Empire Company Limited (TSX:EMP.A) CEO Michael Medline continues his turnaround of Sobeys. Is $40 in the cards in 2019?

| More on:

Was 2018 a great year for Empire Company (TSX:EMP.A) stock or what?

Shareholders of the holding company that owns Sobeys had a total return of 19.0% this past year, 28 percentage points higher than the S&P/TSX Composite Index, and that follows 2017’s total return of 58.4%.

Imagine how CEO Michael Medline must feel. He was granted a special one-time award of 23,753 performance share units (PSUs) for his contribution to the company in the first few months as CEO. On June 27, 2017, the PSUs were worth $22 a share. Today, they’re worth 36% more.

Trading near a 52-week high of $30.62, the highest level since Medline became CEO in January 2017, shareholders are hoping that Medline can continue to work his magic, pushing Empire stock all the way to $40 in 2019.

Can he do it? You better believe it. Here’s why.

A transformational acquisition

Most acquisitions tend to be done by enthusiastic CEOs wanting to accelerate a company’s growth without considering the ramifications of the deal, both financially and culturally, ultimately leading to mediocre or disastrous results. Fortunately for Empire shareholders, Medline has experience making transformational acquisitions.

Medline had been at Canadian Tire for 10 years when he decided to leave the company. It announced his departure in August 2010, but since he wasn’t officially going until October, Medline asked if there was anything he could do to pass the time.

The board asked him to look at whether acquiring Forzani Group (Sport Chek) made sense. He thought it did. They asked him if he would run Forzani if they bought it. He would. They acquired Forzani for $771 million in May 2011. It’s been a big part of Canadian Tire’s growth ever since.

He then became Canadian Tire CEO in 2014 before being replaced by Stephen Wetmore in 2016, the man Medline replaced in 2014.

Another transformational acquisition

Eager to do something special in his career, he couldn’t say no when Empire came calling in late 2016.

Initially, Medline’s goal wasn’t to buy another grocery chain but to turn around Sobeys, which had become a dysfunctional regional operator of grocery stores (Sobeys in the east and Safeway in the west).

Dubbed “Project Sunrise” by the management team, Empire is about halfway through the monumental task of making it a well-oiled, national operator of grocery stores.

In March 2018, I’d suggested that Empire stock would hit $30 by the end of the year, basing my prediction on all the good things Medline and company were doing to boost the margins, while also improving the grocery store’s level of efficiency.

Most of the heavy lifting has already been done, which is why Medline couldn’t resist making an acquisition that should be transformational for the entire Sobeys network of stores.

In September, Empire announced that it would pay $800 million for Ottawa-based Farm Boy, a premium grocery store that focuses on an urban-suburban customer willing to pay a little more for quality fruits and vegetables operating from a smaller footprint without all the non-perishables like toilet paper getting in the way.   

Here’s what I said about the deal in September: “Sobeys would like to double the number of stores over the next five years to 52 locations (14 in Ottawa) and $1 billion in annual revenue … As long as it doesn’t play with the successful formula that Co-CEOs Jean-Louis Bellemare and Jeff York have built over the last few years, Medline’s got another transformative deal on his hands.”

Indeed, he does.

The bottom line on Empire stock

As long as Medline and company continue to make progress on Project Sunrise while also rolling out Farm Boy across Ontario, I could see Empire stock hitting $40 by the end of 2019.

If you’ve got a TFSA, Empire ought to be in it.

Fool contributor Will Ashworth has no position in any stocks mentioned.

More on Investing

Data center servers IT workers
Stocks for Beginners

2 Canadian Stocks With the Potential to Turn $100,000 Into $1 Million

These two Canadian stocks could deliver massive returns in the long run.

Read more »

rising arrow with flames
Dividend Stocks

3 Dividend Stocks I’d Consider Adding More of This Very Moment

With TSX dividends shining in Q2 2026, lock in juicy yields from these resilient payers. Here are 3 Canadian dividend…

Read more »

man makes the timeout gesture with his hands
Dividend Stocks

Why Your TFSA – Not Your RRSP – Should Be Doing the Heavy Lifting

The TFSA’s real superpower is tax-free compounding, and it gets even stronger when you pair it with a proven long-term…

Read more »

A robotic hand interacting with a visual AI touchscreen display.
Tech Stocks

3 Canadian Growth Stocks Worth Considering for a TFSA This Year

These three TSX growth stocks mix real revenue momentum with improving profits, exactly what TFSA investors want for tax-free compounding.

Read more »

ETFs can contain investments such as stocks
Investing

A Passive Income ETF I’d Be Happy to Buy and Never Sell

The Vanguard FTSE Canadian High Dividend Yield Index ETF (TSX:VDY) might be the ultimate passive income ETF to stash away…

Read more »

c
Investing

2 Strong Stocks Worth Putting Your $7,000 TFSA Contribution Behind This Year

Given their solid underlying businesses and visible growth prospects, these two Canadian stocks would be excellent additions to your TFSA.

Read more »

Man looks stunned about something
Dividend Stocks

If Your Portfolio Has You Worried, These 2 Canadian Stocks Are Built to Hold Up

Is market volatility making you feel uneasy about your portfolio? These two stocks could offer much-needed stability.

Read more »

doctor uses telehealth
Investing

The Canadian Stocks I’d Prioritize If I Had $3,000 to Invest Today

Cineplex stock posted strong March box office revenue and secured a favourable amendment to its Bank Credit Agreement.

Read more »